Fotemustine

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Image:Fotemustine.svg
Fotemustine
Systematic (IUPAC) name
diethyl (1-{[(2-chloroethyl)(nitroso)carbamoyl]amino} ethyl)phosphonate
Identifiers
CAS number	92118-27-9
ATC code	L01AD05
PubChem	104799
DrugBank	EXPT03300
Chemical data
Formula	C9H19ClN3O5P
Mol. mass	315.691 g/mol
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	?

WikiDoc Resources for Fotemustine
Articles
Most recent articles on Fotemustine Most cited articles on Fotemustine Review articles on Fotemustine Articles on Fotemustine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Fotemustine Images of Fotemustine Photos of Fotemustine Podcasts & MP3s on Fotemustine Videos on Fotemustine
Evidence Based Medicine
Cochrane Collaboration on Fotemustine Bandolier on Fotemustine TRIP on Fotemustine
Clinical Trials
Ongoing Trials on Fotemustine at Clinical Trials.gov Trial results on Fotemustine Clinical Trials on Fotemustine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Fotemustine NICE Guidance on Fotemustine NHS PRODIGY Guidance FDA on Fotemustine CDC on Fotemustine
Books
Books on Fotemustine
News
Fotemustine in the news Be alerted to news on Fotemustine News trends on Fotemustine
Commentary
Blogs on Fotemustine
Definitions
Definitions of Fotemustine
Patient Resources / Community
Patient resources on Fotemustine Discussion groups on Fotemustine Patient Handouts on Fotemustine Directions to Hospitals Treating Fotemustine Risk calculators and risk factors for Fotemustine
Healthcare Provider Resources
Symptoms of Fotemustine Causes & Risk Factors for Fotemustine Diagnostic studies for Fotemustine Treatment of Fotemustine
Continuing Medical Education (CME)
CME Programs on Fotemustine
International
Fotemustine en Espanol Fotemustine en Francais
Businness
Fotemustine in the Marketplace Patents on Fotemustine
Experimental / Informatics
List of terms related to Fotemustine

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Fotemustine is a nitrosourea alkylating agent.

v • d • e Chemotherapeutic agents/Antineoplastic agents (L01)
Alkylating and alkylating-like agents	Nitrogen mustards: (Chlorambucil, Chlormethine, Cyclophosphamide, Ifosfamide, Melphalan, Bendamustine, Uramustine) Nitrosoureas:(Carmustine, Fotemustine, Lomustine, Streptozocin) Platinum (alkylating-like): (Carboplatin, Cisplatin, Oxaliplatin, Triplatin tetranitrate, Satraplatin) Alkyl sulfonates:(Busulfan, Treosulfan) Hydrazines:(Procarbazine, Dacarbazine, Temozolomide) Aziridines:(ThioTEPA)
Antimetabolites	Folic acid: (Aminopterin, Methotrexate, Pemetrexed, Raltitrexed). Purine:(Cladribine, Clofarabine, Fludarabine, Mercaptopurine, Pentostatin, Thioguanine) Pyrimidine:(Capecitabine, Cytarabine, Decitabine, Fluorouracil, Floxuridine, Gemcitabine)
Spindle poison/mitotic inhibitor	Taxane: (Docetaxel, Larotaxel, Paclitaxel). Vinca: (Vinblastine, Vincristine, Vindesine, Vinorelbine).
Cytotoxic/antitumor antibiotics	Anthracycline family: (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Mitoxantrone, Pixantrone, Valrubicin) streptomyces (Actinomycin, Bleomycin, Mitomycin, Plicamycin) - Hydroxyurea
Topoisomerase inhibitors	Camptotheca: (Camptothecin, Topotecan, Irinotecan, Rubitecan), Podophyllum:(Etoposide, Teniposide)
CI monoclonal antibodies	Receptor tyrosine kinase (Cetuximab, Panitumumab, Trastuzumab) - CD20 (Rituximab, Tositumomab) - other (Alemtuzumab, Bevacizumab, Gemtuzumab)
Photosensitizers	Aminolevulinic acid, Methyl aminolevulinate, Porfimer sodium, Verteporfin
Tyrosine kinase inhibitors	Axitinib, Bosutinib, Cediranib, Dasatinib, Erlotinib, Gefitinib, Imatinib, Lapatinib, Lestaurtinib, Nilotinib, Semaxanib, Sorafenib, Sunitinib, Vandetanib
Cyclin-dependent kinase inhibitor	Seliciclib
Other	retinoids (Alitretinoin, Tretinoin), Fusion protein (Aflibercept) - Altretamine, Amsacrine, Anagrelide, Arsenic trioxide, Asparaginase (Pegaspargase), Bexarotene, Bortezomib, Celecoxib, Denileukin diftitox, Elesclomol, Estramustine, Irofulven, Ixabepilone, Masoprocol, Mitotane, Oblimersen, Testolactone, Tipifarnib, Trabectedin

v • d • e WikiDoc Research Resources for Fotemustine (Click show to right to view)
Articles on Fotemustine	Most recent articles on Fotemustine • Most cited articles on Fotemustine • Review articles on Fotemustine • Articles on Fotemustine in N Eng J Med, Lancet, BMJ
Media (Slides, Video, Images, MP3) on Fotemustine	Powerpoint slides on Fotemustine • Images of Fotemustine • Photos of Fotemustine • Podcasts & MP3s on Fotemustine • Videos on Fotemustine
Evidence Based Medicine Regarding Fotemustine	Cochrane Collaboration on Fotemustine • Bandolier on Fotemustine • TRIP on Fotemustine
Cost Effectiveness of Fotemustine	Cost Effectiveness of Fotemustine
Clinical Trials Involving Fotemustine	Ongoing Trials on Fotemustine at Clinical Trials.gov • Trial results on Fotemustine • Clinical Trials on Fotemustine at Google
Guidelines / Policies / Government Resources (FDA/CDC) Regarding Fotemustine	US National Guidelines Clearinghouse on Fotemustine • NICE Guidance on Fotemustine • NHS PRODIGY Guidance • FDA on Fotemustine • CDC on Fotemustine
Textbook Information on Fotemustine	Books and Textbook Information on Fotemustine
Pharmacology Resources on Fotemustine	Dosing of Fotemustine • Drug interactions with Fotemustine • Side effects of Fotemustine • Allergic reactions to Fotemustine • Overdose information on Fotemustine • Carcinogenicity information on Fotemustine • Fotemustine in pregnancy • Pharmacokinetics of Fotemustine •
Genetics, Pharmacogenomics, and Proteinomics of Fotemustine	Genetics of Fotemustine • Pharmacogenomics of Fotemustine • Proteomics of Fotemustine
Newstories on Fotemustine	Fotemustine in the news • Be alerted to news on Fotemustine • News trends on Fotemustine
Commentary on Fotemustine	Blogs on Fotemustine
Patient Resources on Fotemustine	Patient resources on Fotemustine • Discussion groups on Fotemustine • Patient Handouts on Fotemustine • Directions to Hospitals Treating Fotemustine • Risk calculators and risk factors for Fotemustine
Healthcare Provider Resources on Fotemustine	Symptoms of Fotemustine • Causes & Risk Factors for Fotemustine • Diagnostic studies for Fotemustine • Treatment of Fotemustine
Continuing Medical Education (CME) Programs on Fotemustine	CME Programs on Fotemustine
International Resources on Fotemustine	Fotemustine en Espanol • Fotemustine en Francais
Business Resources on Fotemustine	Fotemustine in the Marketplace • Patents on Fotemustine
Informatics Resources on Fotemustine	List of terms related to Fotemustine

WikiDoc Help Menu Quick Start.. Get Started Here! How to Login How to Search Pages How to Start a New Page How to Edit a Page Cheat Sheet Editing basics Learning Basic Formatting How to make Links in WikiDoc & to External Sites How to Make Lists How to Ignoring Formatting Adding References or Footnotes to Articles Tracking Changes You Have Made How to Put an Article Into a Category When Multiple Topics Should Go To The Same Page (MI, Acute MI, AMI) Using Redirection Advanced editing How to Make Tables How to Insert Images and Other Media How to Add Video Help:How to Make Columns Web Colors How To Make Templates How to Move Pages Inserting Dynamic Dates and Times Inserting WikiDoc Statistics Editing the Table of Contents Communicating your edits Let others know what you changed: The importance of Edit Summaries Minor Edits Edit Conflicts Help Videos You Can Watch Getting Started Video

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .